Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Synthesis and InhA Inhibition of Imidazo[1,2-a]pyridine Derivatives as Anti-tuberculosis Agents
Current Organic Chemistry
2025
Patel T.
Diaryl Pyrazoline, 1,3,4-Oxadizole, and 1,2,4-Triazole Pharmacophore Hybridization: Design, Synthesis, HDAC Inhibition, and Caspase 3/7 Activation Studies
Russian Journal of Bioorganic Chemistry
April 2024
Alzahrani A.Y.A.
Identification of new anti-mycobacterial agents based on quinoline-isatin hybrids targeting enoyl acyl carrier protein reductase (InhA)
Bioorganic Chemistry
March 2024
Khaleel E.F.
A Review on Emerging Impact of Antitubercular Activity of 1,2,4-Triazole Derivatives
Anti Infective Agents
2024
Rangaswamy V.
Sulfur Derivatives of 1,2,4-Triazole: Recently Developed Compounds, Structure Activity Relationship, and Biological Activity: Review article
Iraqi Journal of Pharmaceutical Sciences
2024
Jasim A.M.
Synthesis and In Vitro Antimycobacterial Activity of Some New N-(5-Substituted Phenylthiazol-2-yl) Pyrimidine-5-Carboxamides
Indian Journal of Heterocyclic Chemistry
2023
Almehmadi M.
Recent Discoveries of Nitrogen-Containing Heterocyclic Compounds as InhA Inhibitors against Mycobacterium tuberculosis: An Overview
Infectious Disorders Drug Targets
December 2022
Gupta P.D.
An overview on applications of SwissADME web tool in the design and development of anticancer, antitubercular and antimicrobial agents: A medicinal chemist's perspective
Journal of Molecular Structure
5 July 2022
Bakchi B.
Recent Trends in Drug Development for the Treatment of Adenocarcinoma Breast Cancer: Thiazole, Triazole, and Thiosemicarbazone Analogues as Efficient Scaffolds
Anti Cancer Agents in Medicinal Chemistry
July 2022
Scarim C.B.
Advances in the application of 1,2,4-triazole-containing hybrids as anti-tuberculosis agents
Future Medicinal Chemistry
December 2021
Cao Y.
Development and investigation of thiazolidinedione and pyrazoline compounds as antiangiogenic weapons targeting VEGFR-2
Future Medicinal Chemistry
November 2021
Upadhyay N.
Hypoglycemic and Hypolipidemic Swords: Synthesis and In-vivo Biological Assessment of 5-benzylidene-2,4-thiazolidinediones
Iranian Journal of Pharmaceutical Research
October 2021
Patil V.
Thiazole, triazole, thio- and semicarbazone derivatives - Promising moieties for drug development for the treatment of tuberculosis
European Journal of Medicinal Chemistry Reports
July 2021
Scarim C.B.
Thiazolidinedione "magic Bullets" Simultaneously Targeting PPARγand HDACs: Design, Synthesis, and Investigations of their in Vitro and in Vivo Antitumor Effects
Journal of Medicinal Chemistry
27 May 2021
Tilekar K.